| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10800939 | Biochimica et Biophysica Acta (BBA) - General Subjects | 2009 | 9 Pages |
Abstract
Anti-amyloid compounds could potentially reduce the loss of β-cell mass in type 2 diabetes and maintain healthy human islet cultures for β-cell replacement therapies.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Kathryn J. Potter, Louise A. Scrocchi, Garth L. Warnock, Ziliang Ao, Marika A. Younker, Lawrence Rosenberg, Mark Lipsett, C. Bruce Verchere, Paul E. Fraser,